San Gregorio di Catania, Italy

Clelia Carmen Galati

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Clelia Carmen Galati: Innovator in Real-Time Quantitative PCR Technology

Introduction

Clelia Carmen Galati is a distinguished inventor based in San Gregorio di Catania, Italy. He has made significant contributions to the field of molecular biology, particularly in the development of innovative technologies for real-time quantitative PCR. With a total of 8 patents to his name, Galati's work has advanced the capabilities of nucleic acid detection.

Latest Patents

Among his latest patents is an integrated device for real-time quantitative PCR. This method allows for the real-time quantitative detection of single-type target nucleic acid sequences amplified using PCR in a microwell. The process involves introducing a sample containing target nucleic acid sequences, magnetic primers, and labeling probes into the microwell. An amplification cycle is performed to create labeled amplicons. The magnetic primers are then attracted to a surface through a magnetic field, forming a layer that includes labeled amplification products and free magnetic primers. Finally, the labeled amplification products are detected in the layer using a surface-specific reading method.

Career Highlights

Clelia Carmen Galati is currently employed at STMicroelectronics S.r.l., where he continues to innovate and develop cutting-edge technologies. His work has not only contributed to the scientific community but has also enhanced the capabilities of diagnostic tools used in various applications.

Collaborations

Throughout his career, Galati has collaborated with notable colleagues, including Lucio Renna and Natalia Maria Rita Spinella. These collaborations have fostered a productive environment for innovation and have led to the successful development of several patents.

Conclusion

Clelia Carmen Galati's contributions to the field of real-time quantitative PCR technology exemplify his dedication to innovation and scientific advancement. His patents reflect a commitment to improving molecular detection methods, making a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…